Danlou Tablet Improves Chronic Intermittent Hypoxia-Induced Dyslipidemia and Arteriosclerosis by HIF-1α-Angptl4 mRNA Signaling Pathway

被引：0
|
作者：
Jing-jing Tang
Guang-xi Li
Zhi-guo Liu
Rong Yi
Dong Yu
Yue-bo Zhang
Shuang-qiao Zhao
Shi-han Wang
机构：
[1] Chinese Academy of Chinese Medical Sciences,Department of Pneumology, Guang’anmen Hospital
[2] Mayo Clinic,Department of Pulmonary and Critical Care Medicine
[3] Chinese Academy of Chinese Medical Sciences,Drug Clinical Trial Agency, Guang’anmen Hospital
[4] Mayo Clinic,Department of Cardiovascular Medicine
[5] Chinese Academy of Chinese Medical Sciences,Department of Gynecology, Guang’anmen Hospital
[6] Chinese Academy of Chinese Medical Sciences,Department of Cardiovascular Medicine, Guang’anmen Hospital
来源：
Chinese Journal of Integrative Medicine | 2022年 / 28卷
关键词：
Danlou Tablet; Chinese medicine; hypoxia-induced factor; angiopoietin-like 4; dyslipidemia; arteriosclerosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：509 / 517
页数：8
相关论文
共 50 条
  • [1] Danlou Tablet Improves Chronic Intermittent Hypoxia-Induced Dyslipidemia and Arteriosclerosis by HIF-1α-Angptl4 mRNA Signaling Pathway
    TANG Jing-jing
    LI Guang-xi
    LIU Zhi-guo
    YI Rong
    YU Dong
    ZHANG Yue-bo
    ZHAO Shuang-qiao
    WANG Shi-han
    Chinese Journal of Integrative Medicine, 2022, 28 (06) : 509 - 517
  • [2] Danlou Tablet Improves Chronic Intermittent Hypoxia-Induced Dyslipidemia and Arteriosclerosis by HIF-1α-Angptl4 mRNA Signaling Pathway
    TANG Jingjing
    LI Guangxi
    LIU Zhiguo
    YI Rong
    YU Dong
    ZHANG Yuebo
    ZHAO Shuangqiao
    WANG Shihan
    Chinese Journal of Integrative Medicine , 2022, (06) : 509 - 517
  • [3] Danlou Tablet (&x4e39;&x848c;(sic)) Improves Chronic Intermittent Hypoxia-induced Dyslipidemia and Arteriosclerosis by HIF-1 α-Angptl4 mRNA Signaling Pathway
    Tang Jing-jing
    Li Guang-xi
    Liu Zhi-guo
    Yi Rong
    Yu Dong
    Zhang Yue-bo
    Zhao Shuang-qiao
    Wang Shi-han
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2022, 28 (06) : 509 - 517
  • [4] Danlou Tablet May Alleviate Vascular Injury Caused by Chronic Intermittent Hypoxia through Regulating FIH-1, HIF-1, and Angptl4
    Rong, Yi
    Wu, Qian
    Tang, Jingjing
    Liu, Zhiguo
    Lv, Qianyu
    Ye, Xuejiao
    Dong, Yu
    Zhang, Yuebo
    Li, Guangxi
    Wang, Shihan
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [5] CaMKIIγ advances chronic intermittent hypoxia-induced cardiomyocyte apoptosis via HIF-1 signaling pathway
    Xuechao Yang
    Xinyu Sha
    Gang Wang
    Duo Xu
    Jingji Zhang
    Ming Tang
    Jiahai Shi
    Sleep and Breathing, 2025, 29 (1)
  • [6] Imaging hypoxia-induced HIF-1α signaling by PET.
    Serganova, I
    Beresten, T
    Ageyeva, L
    Ponomarev, V
    Doubrovin, M
    Soghomonian, S
    Vider, J
    Balatoni, J
    Finn, R
    Blasberg, R
    Tjuvajev, JG
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 69P - 69P
  • [7] Autophagy regulates hypoxia-induced osteoclastogenesis through the HIF-1α/BNIP3 signaling pathway
    Zhao, Yi
    Chen, Gang
    Zhang, Wei
    Xu, Ning
    Zhu, Jun-Yi
    Jia, Jun
    Sun, Zhi-Jun
    Wang, Yi-Ning
    Zhao, Yi-Fang
    JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (02) : 639 - 648
  • [8] Hypertriglyceridemia Induced By Chronic Intermittent Hypoxia Is Mediated By Hypoxia Inducible Factor (hif-1)
    Yao, Q.
    Drager, L. F.
    Shin, M. -K.
    Jun, J. C.
    Halberg, N.
    Scherer, P. E.
    Semenza, G. L.
    Polotsky, V. Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [9] EFFECTS OF CHRONIC INTERMITTENT HYPOXIA, ANGPTL4 AND ANGPTL8 ON DYSLIPIDEMIA IN OBSTRUCTIVE SLEEP APNEA: EVIDENCE FROM TWO MATCHED CLINICAL STUDIES
    Qian, Y.
    Li, X.
    Xu, H.
    Li, Z.
    Shi, Y.
    Wu, X.
    Guan, J.
    Yi, H.
    Yin, S.
    SLEEP MEDICINE, 2019, 64 : S310 - S311
  • [10] Effect of chronic intermittent hypoxia-induced HIF-1α/ATAD2 expression on lung cancer stemness
    Hao, Shengyu
    Li, Fan
    Jiang, Pan
    Gao, Jian
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2022, 27 (01)
12345